Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements
Search Results:
1-15 of 50577 results
iCardiac Technologies IQ-CSRC study shows potential for faster drug development
The Food and Drug Administration hosted the Cardiac Safety Research Consortium (CSRC) meeting to release the results of the IQ-CSRC Study demonstrating the ability to conduct robust cardiac safety characterization several years earlier in clinical development.
Drug Research > Drug Discovery & Development > News
NutraFuels receives purchase order from RC Taylor distributing
NutraFuels, manufacturer of oral spray dietary supplements, announced that the company has received and fulfilled its first purchase order from R.C. Taylor Distributing.
Production & Manufacturing > OTC > News
Iodine launches cold and flu app to helps smart consumers find best OTC options for their symptoms
Iodine, a developer of health information website Iodine.com, has launched a new web app for cold and flu season.
Production & Manufacturing > OTC > News
BioBlast receives notice of patent issuance for new fusion protein-based platform to treat Friedrich's Ataxia
Bio Blast Pharma a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases, announced today it has received a Notice of Patent Issuance for patent no. 8,912,147 from the US Patent and Trademark Office (USPTO) for a composition-of-matter patent for its novel fusion protein for Friedrich's Ataxia (referred to as BB-FA) that is built on its mitochondrial protein replacement (mPRT) platform.
Automation > IT & Software > News
CannaPharmaRx, PharmaDirections to start research & discovery program in Cannabinoid Science
CannaPharmaRx, the New Jersey-based pharmaceutical company, will be working with PharmaDirections, a pharmaceutical project management and consulting group, as it launches its R&D platform to investigate product opportunities in endocannabinoid science for ultimate commercialization in global markets.
Contract Research & Services > Contract Research > News
Clementia begins natural history trial in FOP patients
By PBR Staff Writer
Clementia Pharmaceuticals has started a natural history trial in patients with fibrodysplasia ossificans progressiva (FOP), a rare, severely disabling genetic disease.
Contract Research & Services > Clinical Trials > News
Halozyme, Janssen to develop and commercialize products using Enhanze technology
By PBR Staff Writer
US-based biopharmaceutical firm Halozyme Therapeutics has entered into a worldwide collaboration and license agreement with Janssen Biotech to develop and commercialize products combining Janssen compounds with Halozyme's Enhanze technology.
Automation > IT & Software > News
FDA accepts filing Apotex's biosimilar application for pegfilgrastim
By PBR Staff Writer
The US Food and Drug Administration has accepted for filing Canadian pharmaceutical firm Apotex's application for pegfilgrastim, a biosimilar version of Amgen's Neulasta.
Regulatory Affairs > News
HedgePath gets FDA nod to begin proposed cancer drug development
By PBR Staff Writer
HedgePath Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA) for the first investigational new drug (IND) application to start development of its proposed cancer treatment.
Production & Manufacturing > Process & Production > News
BioLineRx, Novartis to develop and commercialize Israeli-sourced drug candidates
By PBR Staff Writer
Clinical-stage biopharmaceutical company BioLineRx and Novartis Pharma have reached a multi-year strategic collaboration agreement to support the development and commercialization of Israeli-sourced drug candidates.
Drug Research > Drug Discovery & Development > News
Ossianix and Lundbeck agree to research collaboration expansion on CNS therapeutics
By PBR Staff Writer
US-based research firm Ossianix and Denmark’s Lundbeck have agreed to expand and extend a strategic research collaboration to deliver next generation CNS biotherapeutics.
Contract Research & Services > Contract Research > News
Pfizer begins Phase II trial of PF-06252616 to treat duchenne muscular dystrophy
By PBR Staff Writer
Pfizer has started patient enrollment in a multicenter Phase II clinical trial of PF-06252616, an experimental, infused, anti-myostatin monoclonal antibody, to treat Duchenne muscular dystrophy (DMD).
Contract Research & Services > Clinical Trials > News
Janssen Healthcare Innovation two-time Finalists at eyeforpharma Barcelona Awards
Janssen Healthcare Innovation’s Care4Today programme is set to take two of the highest honours at the 2015 eyeforpharma Barcelona Awards as the shortlist was today announced.
Press Releases
Apps & Digital Resources Vie for Top Honour at eyeforpharma Barcelona Awards
Two thirds of the finalists for the ‘Most Valuable Patient Initiative’ in the 2015 eyeforpharma Barcelona Awards have used interactive digital resources or mobile applications to engage with the patient; a tell-tale sign of the dominance of patient engagement as a focus for pharma right now. The list of finalists, announced today, includes Abbvie, AstraZeneca, Bayer, Janssen Healthcare Innovation and Novartis all vying for the ultimate accolade in pharma; to be crowned ‘most valuable’ to their patients.
Press Releases
Apps & Digital Resources Vie for Top Honour at eyeforpharma Barcelona Awards
Two thirds of the finalists for the 'Most Valuable Patient Initiative' in the 2015 eyeforpharma Barcelona Awards have used interactive digital resources or mobile applications to engage with the patient; a tell-tale sign of the dominance of patient engagement as a focus for pharma right now. The list of finalists, announced today, includes Abbvie, AstraZeneca, Bayer, Janssen Healthcare Innovation and Novartis all vying for the ultimate accolade in pharma; to be crowned 'most valuable' to their patients.
Suppliers

PBR Supplier Recommendations

Apps & Digital Resources Vie for Top Honour at eyeforpharma Barcelona Awards
Two thirds of the finalists for the 'Most Valuable Patient Initiative' in the 2015 eyeforpharma Barcelona Awards have used interactive digital resources or mobile applications to engage with the patient; a tell-tale sign of the dominance of patient engagement as a focus for pharma right now. The list of finalists, announced today, includes Abbvie, AstraZeneca, Bayer, Janssen Healthcare Innovation and Novartis all vying for the ultimate accolade in pharma; to be crowned 'most valuable' to their patients.... Suppliers
Vetter Pharma International - High-Quality Aseptically Pre-Filled Injection Systems
From preclinical development through commercial supply.... Drug Research > Drug Delivery > Suppliers
leon-nanodrugs - Nanotechnology for Drug Formulations
leon-nanodrugs is an expert drug development company located in Munich Germany. Our core business is the reformulation of poor soluble oral and parenteral pharmaceutical active pharmaceutical ingredients (APIs) based on our proprietary nano-precipitation technology platform (MJR-technology), is under patent protection until 2030. ... Drug Research > Drug Delivery > Suppliers
Eppendorf - We Know Bioprocessing
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO² incubators, shakers, and cell manipulation systems. Consumables such as pipette tips, test tubes, microtiter plates, and disposable bioreactors complement the range of highest-quality premium products.... Suppliers
MSP Kofel – Analytical Accessories and Software Specialists
MSP Kofel provides analytical scientists with software and databases for interpretation, confirmation and archival of spectra, chromatographic data, structures and chemical compound information.... Automation > IT & Software > Suppliers
See more

PBR White Paper Recommendations

Quality of Steel By Natoli Engineering Company
Steel quality is the summation of how well a steel meets its specified chemistry, the cleanliness of the steel or degree to which it is free of impurities or inclusion, homogeneity of the microstructure, grain/carbide size and in some instances if it meets the mechanical requirements for that particular steel. In the design and manufacture of tablet compression tooling, nothing is more important than the quality of the materials being used. The best manufacturing principals maintaining the tightest tolerances will result in tool failure if the initial material quality is poor. Material quality is the fundamental building block upon which all successive value added steps are laid. The majority of all tablet compression tooling is produced from steel and steel quality is the subject of this article.... Production & Manufacturing > Manufacturing > White Papers First Impressions: Tablet Shape Can Impact Patient Acceptance By Natoli Engineering Company
First impressions are everything. This is especially true for pharmaceutical, nutritional and confectionery tablets. Discriminating consumers may decide if they will be repeat customers based on a tablet’s appearance and their experience with it. This article discusses the limitations of the flat faced bevel edge and the benefits of a flat faced radius edge tablet design. ... Production & Manufacturing > Manufacturing > White Papers Advanced Biofuel Development Using Parallel Bioreactor Systems By Eppendorf
To make biofuels such as bioethanol and biodiesel competitive with fossil fuels extensive research in the field of process development is needed. Taking into account the special requirements of biofuel production, such as high temperatures, multi-step procedures and anaerobic conditions, effective tools for streamlining development efforts must be provided.... White Papers Open Interface By Eppendorf
DASware® migrate: Manage your bioprocess data with DASGIP®.... White Papers Truly Parallel - Microbiology By Eppendorf
DASGIP® Bioreactor Systems for Microbiology.... White Papers See more
1-15 of 50577 results